6AL4
CRYSTAL STRUCTURE OF ANTI-CD19 ANTIBODY B43 FAB
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-F |
Synchrotron site | APS |
Beamline | 21-ID-F |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-06-18 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 0.9785 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 73.100, 127.360, 219.390 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 20.000 - 2.450 |
R-factor | 0.20645 |
Rwork | 0.206 |
R-free | 0.23642 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5i15 |
RMSD bond length | 0.005 |
RMSD bond angle | 1.016 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0049) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.470 |
High resolution limit [Å] | 2.380 | 2.380 |
Rmerge | 0.071 | 0.563 |
Number of reflections | 80381 | 7505 |
<I/σ(I)> | 22.3 | 3.4 |
Completeness [%] | 96.9 | 91.7 |
Redundancy | 5.7 | 5.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 9.1 | 293 | 20% PEG 3350, 0.2 M NA PHOSPHATE DIBASIC |